Finance

Lists
Q3 2026 earnings • released • EPS beat +1.74% • Revenue miss -0.74%
See results
CFG:NYSE
Citizens Financial Group Inc
$62.76
-0.87%
(-0.55) 1D
$62.76
0.00% (0.00)
After hours
Closed: Oct 19, 4:00:11 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CFG...
Open
$62.96
High
$63.33
Low
$62.35
Mkt. cap
26.43B
Avg. vol.
4.31M
Volume
7.84M
Dividend
3.31%
Quarterly dividend
$0.52
Ex-dividend date
Jul 30, 2026
P/E ratio
12.66
52-wk high
$75.33
52-wk low
$49.00
EPS
$4.96
Beta
1.05
Shares outstanding
421.18M
No. of employees
18K
Open
$62.96
High
$63.33
Low
$62.35
Mkt. cap
26.43B
Avg. vol.
4.31M
Volume
7.84M
Dividend
3.31%
Quarterly dividend
$0.52
Ex-dividend date
Jul 30, 2026
P/E ratio
12.66
52-wk high
$75.33
52-wk low
$49.00
EPS
$4.96
Beta
1.05
Shares outstanding
421.18M
No. of employees
18K
News stories
From web sources and news partners
Profile
Citizens Financial Group, Inc. is an American bank holding company, headquartered in Providence, Rhode Island. The company owns the bank Citizens Bank, N.A., which operates in the U.S. states of Connecticut, Delaware, Florida, Maryland, Massachusetts, Michigan, New Hampshire, New Jersey, New York, Ohio, Pennsylvania, Rhode Island, Vermont, and Virginia, as well as Washington, DC. Between 1988 and its 2014 initial public offering, Citizens was a wholly owned subsidiary of Royal Bank of Scotland. RBS sold its last 20.9% stake in the company in October 2015. Citizens operates 1,078 branches and four wealth centers as of August 31, 2023, and over 3,200 ATMs across 14 states under the Citizens Bank brand. Citizens is the 18th largest bank in the United States as of September 30, 2025. Wikipedia
About Citizens Financial Group Inc
CEOBruce Van Saun
Employees17.6K
Founded1828
Headquarters-
SectorBank
Websitecitizensbank.com
Analyst ratings
Based on 14 analysts giving stock ratings to CFG in the past 3 months
Strong buy
Buy
12
Hold
2
Sell
0
12-month forecast
Based on 14 Wall Street analysts offering 12 month price targets for CFG in the last 3 months.
Highest
Current $62.76
$87.00 (+38.62%)
Average
$78.42 (+24.95%)
Lowest
$72.50 (+15.52%)
Analyst
Recommendation
Action
Price target
Projected
Date
Daniel Tamayo
Raymond James
Buy
Maintained
$76.00
+21.1%
10/19/2026
Ryan Kenny
Morgan Stanley
Buy
Reiterated
$87.00
+38.6%
10/19/2026
David George
Robert W. Baird
Hold
Maintained
$75.00
+19.5%
10/19/2026
Jason Goldberg
Barclays
Buy
Maintained
$81.00
+29.1%
10/19/2026
Ebrahim Poonawala
Bank of America Securities
Buy
Maintained
-
-
10/19/2026
Gerard Cassidy
RBC Capital
Buy
Reiterated
$79.00
+25.9%
10/16/2026
Dave Rochester
Cantor Fitzgerald
Buy
Maintained
$78.00
+24.3%
10/14/2026
Scott Siefers
TD Cowen
Buy
Initiated
$75.00
+19.5%
10/08/2026
Unknown Analyst
TD Cowen
Buy
Initiated
$75.00
+19.5%
10/08/2026
Erika Najarian
UBS
Buy
Maintained
$77.00
+22.7%
10/05/2026
Vivek Juneja
J.P. Morgan
Buy
Maintained
$72.50
+15.5%
10/02/2026
John Pancari
Evercore ISI
Buy
Maintained
$78.00
+24.3%
10/01/2026
Brian Foran
Truist Financial
Hold
Maintained
$77.00
+22.7%
09/23/2026
Kevin Heal
Argus Research
Buy
Maintained
$80.00
+27.5%
07/29/2026
Ben Gerlinger
Citi
Buy
Maintained
$84.00
+33.8%
07/21/2026
Ryan Nash
Goldman Sachs
Buy
Maintained
$84.00
+33.8%
07/16/2026
Peter Winter
D.A. Davidson
Buy
Maintained
$85.00
+35.4%
07/17/2026
Manan Gosalia
Morgan Stanley
Buy
Reiterated
$79.00
+25.9%
07/17/2026
Matthew Breese
Stephens
Hold
Maintained
$70.00
+11.5%
07/17/2026
Christopher Mcgratty
KBW
Buy
Maintained
$79.00
+25.9%
07/16/2026
David Chiaverini
Jefferies
Buy
Maintained
$90.00
+43.4%
07/16/2026
David Siffringer
Cantor Fitzgerald
Buy
Reiterated
$75.00
+19.5%
06/09/2026
Unknown Analyst
UBS
Buy
Maintained
$74.00
+17.9%
02/04/2026
Last report
Oct 16, 2026
Fiscal period
Q3 2026
$1.41 / $1.39
+1.74%beat
Revenue / Est. (USD)
2.32B / 2.34B
-0.74%miss
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
1.96B
2.02B
2.03B
2.15B
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.21B
1.21B
1.27B
1.26B
Operating expense
1.34B
1.37B
1.38B
1.39B
Total operating expenses
1.34B
1.37B
1.38B
1.39B
Operating income
629.00M
651.00M
650.00M
755.00M
Other non operating income
-
-
-
-
EBT including unusual items
629.00M
677.00M
650.00M
755.00M
EBT excluding unusual items
629.00M
651.00M
650.00M
755.00M
Income tax expense
135.00M
149.00M
133.00M
168.00M
Effective tax rate
21.46%
22.01%
20.46%
22.25%
Other operating expenses
122.00M
156.00M
106.00M
129.00M
Net income
494.00M
528.00M
517.00M
587.00M
Net profit margin
25.15%
26.14%
25.49%
27.32%
Earnings per share
1.05
1.13
1.13
1.30
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-2.00M
-8.00M
-7.00M
-6.00M
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps